Cargando…
Histone methyltransferase and drug resistance in cancers
A number of novel anticancer drugs have been developed in recent years. However, the mortality of cancer patients remains high because of the emergence of drug resistance. It was reported that drug resistance might involved in changes in gene expression without changing genotypes, which is similar t...
Autores principales: | Yang, Cheng, Zhang, Jiayu, Ma, Yukui, Wu, Chunfu, Cui, Wei, Wang, Lihui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7455899/ https://www.ncbi.nlm.nih.gov/pubmed/32859239 http://dx.doi.org/10.1186/s13046-020-01682-z |
Ejemplares similares
-
DNA Methyltransferases in Cancer: Biology, Paradox, Aberrations, and Targeted Therapy
por: Zhang, Jiayu, et al.
Publicado: (2020) -
Histone H3K4 Methyltransferases as Targets for Drug-Resistant Cancers
por: Yang, Liu, et al.
Publicado: (2021) -
Histone methyltransferase SETD2: a potential tumor suppressor in solid cancers
por: Chen, Rui, et al.
Publicado: (2020) -
Role of several histone lysine methyltransferases in tumor development
por: LI, JIFU, et al.
Publicado: (2016) -
The role of histone lysine methyltransferase NSD3 in cancer
por: Han, Xu, et al.
Publicado: (2018)